Blue Oak Pharmaceuticals has a total of 23 patents globally, out of which no patents have been granted. Of these 23 patents, more than 86% patents are active. The United States of America seems to be the main focused R&D centre and also is the origin country of Blue Oak Pharmaceuticals.
Blue Oak Pharmaceuticals was founded in 2016. Th Company is dedicated on developing the next generation of treatments for neurological illnesses. The company anticipates that the first-in-class medications will be discovered by combining unique, custom-designed favoured chemo types with proven in vivo systems neurobiology assays and brain circuit imaging.
Do read about some of the most popular patents of Blue Oak Pharmaceuticals which have been covered by us in this article and also you can find Blue Oak Pharmaceuticals patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Blue Oak Pharmaceuticals patent portfolio.
How many patents does Blue Oak Pharmaceuticals have?
Blue Oak Pharmaceuticals has a total of 23 patents globally. These patents belong to 3 unique patent families. Out of 23 patents, 20 patents are active.
How Many Patents did Blue Oak Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Blue Oak Pharmaceuticals Applications Filed | Blue Oak Pharmaceuticals Patents Granted |
| 2023 | 2 | – |
| 2022 | 3 | – |
| 2020 | 18 | – |
How many Blue Oak Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Blue Oak Pharmaceuticals File in Different Countries?
Countries in which Blue Oak Pharmaceuticals Filed Patents
| Country | Patent |
| Australia | 2 |
| Brazil | 2 |
| Canada | 2 |
| China | 2 |
| Europe | 2 |
| Hong Kong (S.A.R.) | 2 |
| India | 2 |
| Japan | 2 |
| Korea (South) | 2 |
| United States Of America | 2 |
Where are Research Centers of Blue Oak Pharmaceuticals Patents Located?
The Research Center of Blue Oak Pharmaceuticals is in the United States of America.
What Percentage of Blue Oak Pharmaceuticals US Patent Applications Were Granted?
Blue Oak Pharmaceuticals (Excluding its subsidiaries) has filed 2 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 0 have been granted leading to a grant rate of 0%.
Below are the key stats of Blue Oak Pharmaceuticals patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for Blue Oak Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Dechert Llp | 2 | 0% |
List of Blue Oak Pharmaceuticals Patents
| Blue Oak Pharmaceuticals Patents | Title |
| US20230109801A1 | Compounds And Compositions For Treating Cns Disorders |
| US20230116114A1 | Compounds And Compositions For Treating Cns Disorders |
| EP4084795A1 | Compounds And Compositions For Treating Cns Disorders |
| EP4084797A1 | Compounds And Compositions For Treating Cns Disorders |
| CN114929235A | Compounds And Compositions For Treating Cns Disorders |
| CN114929228A | Compounds And Compositions For Treating Cns Disorders |
| CA3161867A1 | Compounds And Compositions For Treating Cns Disorders |
| CA3165217A1 | Compounds And Compositions For Treating Cns Disorders |
| AU2020417248A1 | Compounds And Compositions For Treating Cns Disorders |
| AU2020416203A1 | Compounds And Compositions For Treating Cns Disorders |
| JP2023509700A | Compounds And Compositions For Treating Cns Disorders |
| JP2023509453A | Compounds And Compositions For Treating Cns Failure |
| HK40082254A | Compounds And Compositions For Treating Cns Disorders |
| HK40082232A | Compounds And Compositions For Treating Cns Disorders |
| IN202217034823A | Compounds And Compositions For Treating Cns Disorders |
| IN202217032225A | Compounds And Compositions For Treating Cns Disorders |
| KR1020220123404A | Compounds And Compositions For Treating Cns Disorders |
| KR1020220123406A | Compounds And Compositions For Treating Cns Disorders |
| BR112022010021A2 | Compounds And Compositions For Treatment Of Central Nervous System (Cns) Disorders |
| BR112022010641A2 | Compounds And Compositions For Treatment Of Central Nervous System (Cns) Disorders |
| WO2022204150A1 | Compounds And Compositions For Treating Cns Disorders |
| WO2021138314A1 | Compounds And Compositions For Treating Cns Disorders |
| WO2021138315A1 | Compounds And Compositions For Treating Cns Disorders |
What are Blue Oak Pharmaceuticals key innovation segments?
What Technologies are Covered by Blue Oak Pharmaceuticals?
The chart below distributes patents filed by Blue Oak Pharmaceuticals